Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Portland, OR, Feb. 01, 2023 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Foot Orthotic Insoles Market size was estimated at $3.2 billion in...
-
New York, USA, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The Global Oncology Drugs Market to Surpass USD 368 Billion by 2027, Assesses DelveInsight The oncology drugs market is expected to grow due to the...
-
Pune, India, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The oncology drugs market was USD 141.33 billion in 2019 and is projected to USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the...
-
Pune, Indai, June 16, 2022 (GLOBE NEWSWIRE) -- The global oncology drugs market size was valued at USD 141.33 billion in 2019 and is projected to reach USD 394.24 billion by 2027, exhibiting a CAGR...
-
New York, April 13, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer...
-
Bryan Giraudo, COO & CFO of U.S. biopharmaceutical company Gossamer Bio, joins the Company’s Board as independent member Paris (France), Nov. 23, 2021 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext...
-
Pune, India, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The global Oncology Drugs Market size is expected to reach USD 286.67 billion in 2028, exhibiting a CAGR of 9.1% during the forecast period. The...
-
Pune, India, March 04, 2021 (GLOBE NEWSWIRE) -- The global oncology drugs market size is expected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period. The...
-
Pune, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The global oncology drugs market size is expected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period. The...
-
NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - March 23, 2009) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) is pleased to announce the appointment of Mr. William D. Rueckert to its Board of...